🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized open label study that implies the administration...
Status
Unknown
Location
Centro Cardiologico Monzino, IRCCS
Start Date
2011-09
Trial ID
NCT01466452
This is a multicenter, randomized, double-blind, cross-over study to compar...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-03
Trial ID
NCT00385944
Treatments Being Tested
Study to determine the effect of steady-state plasma concentration of Tipra...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT02251795
Treatments Being Tested
The main objective of this study is to demonstrate that a single anticoagul...
Status
Completed
Location
CHRU de Montpellier - Hôpital Arnaud de Villeneuve
Start Date
2017-06-01
Trial ID
NCT02735902
Treatments Being Tested
The purpose of the study is to determine the pharmacokinetics and safety of...
Status
Terminated
Location
DaVita Clinical Research
Start Date
2009-09
Trial ID
NCT00984113
Treatments Being Tested
This study is designed to assess tolerability of the weight-adjusted dose o...
Status
Completed
Location
The Lindner Research Center
Start Date
2019-02-18
Trial ID
NCT03844191
Treatments Being Tested
Antiplatelet agents are cornerstones for management of ischemic heart disea...
Status
Completed
Location
Prof. HF Tse
Start Date
2017-01
Trial ID
NCT03881943
Treatments Being Tested
The goal of this clinical trial is to compare the pharmacokinetics (PK) pha...
Status
Terminated
Location
Omega Research Orlando, LLC
Start Date
2023-03-11
Trial ID
NCT05625347
An open label, balanced, randomized, three-treatment, three-period, six-seq...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-14
Trial ID
NCT01847404
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested